Fig. 6
From: The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes
Down-regulation of glucose levels in the media of iPSC-derived cardiomyocytes following treatment with trastuzumab. Standard deviation (SD) calculated from three replicates. Time course of glucose concentration in the media of iPSC-derived cardiomyocytes treated with trastuzumab versus untreated (control). *p = 0.04 (72 h), p = 0.026 (96 h); **p = 0.001 (24 h), ***p < 0.0002 (48 h)